HA400 Unit 7 Implant Conflict of Interest Analysis Example

Public All Along: A Conflict of Interest Analysis of a Composite Hospital's Hip Implant Review, Where the Orthopedic Chair Who Presented the Clinical Comparison Had Received Consulting Fees and Royalties From the Winning Bidder

[Student Name]

Purdue University Global

HA400: Health Care Ethics, Law, and Governance

Unit 7 Conflict of Interest Analysis

[Instructor Name]

[Date]

The hospital, the surgeon, the manufacturer and every figure are composite and bracketed; the analysis demonstrates how to test facts against a policy and is not legal advice.

Timeline

[January], Year 1: The chair signs the hospital's annual conflict of interest disclosure form and lists no relationships with manufacturers. Years 1 to 3: The federal Open Payments database shows payments from [Manufacturer A] to the chair of about [$48,000] in consulting fees and [$110,000] in royalties. [March], Year 3: The value analysis committee reviews hip implant systems from three manufacturers. The chair presents the clinical comparison and recommends [Manufacturer A]. [April], Year 3: The committee votes six to one for [Manufacturer A]. The contract is worth about [$2.1 million] over three years. [September], Year 3: A purchasing analyst, checking Open Payments for an unrelated reason, notices the chair's payments and reports them to the compliance officer.

Sources for Each Fact

The disclosure form comes from the medical staff office. The payment data come from the public Open Payments site, where manufacturers must report payments and other transfers of value to physicians (42 C.F.R. § 403.904, 2024). The vote and the presentation come from the committee minutes.

What the Policy Required

The hospital's conflict of interest policy, in summary:

1. Annual disclosure of any financial relationship with a company that sells to the hospital, above [$5,000] a year.

2. Disclosure again at the start of any meeting where such a company's products are discussed.

3. Abstention from presenting, discussing and voting on any decision that involves a company with which the person has a disclosed relationship.

4. Review of disclosures by the compliance officer, who may set further limits.

Testing the Facts Against the Policy

Provision 1: The chair received payments far above the threshold and disclosed none. This is a failure to disclose. Provision 2: The minutes show no disclosure at the March meeting. A second failure to disclose. Provision 3: The chair presented the comparison and voted. If he had disclosed, he should have left the room after answering factual questions. This is a failure to abstain. Provision 4: The compliance officer had nothing to review because nothing was disclosed. But the hospital also did not compare disclosures with the public payment data, which was available. The payments were never hidden; the hospital simply never looked at the public record against its own forms.

Why This Matters

A conflict of interest is a set of circumstances in which personal gain, such as fees or royalties, could unduly sway the judgment a professional owes to something more important, here patients and the hospital's purchasing. A conflict does not prove that judgment was biased; it creates a risk that others cannot rule out (Institute of Medicine, 2009). Surveys have found that relationships between physicians and industry are common, which is why policies depend on disclosure and management rather than prohibition (Campbell et al., 2007).

Was the Decision Itself Wrong?

The analysis cannot tell from the record whether [Manufacturer A]'s implant was the best choice. Its system may well have been clinically sound. The problem is that the committee cannot now show that its decision rested on an unbiased comparison, because the person who prepared the comparison had a financial interest in the result.

Legal Considerations

Payments to a physician who influences a purchasing decision can raise questions under federal anti-kickback law if they are intended to induce business. Nothing in the record suggests that intent, and royalties may reflect legitimate design work. The hospital's counsel should review the facts, but this analysis treats the matter mainly as a policy and governance failure.

Who Should Have Abstained

The chair. No other committee member reported any relationship with the bidders, and a check of the public database during this analysis found none above the threshold.

What a Clean Record Would Look Like

1. A disclosure form listing the chair's relationship with [Manufacturer A].

2. Minutes showing the disclosure at the start of the meeting.

3. A clinical comparison prepared by someone without a conflict, such as another orthopedic surgeon or an outside reviewer.

4. Minutes showing the chair left the room before discussion and the vote.

What Happens Now

1. The compliance officer refers the chair's nondisclosure to the medical staff process for action under the bylaws.

2. The committee repeats the review with an independent clinical comparison before the contract's first renewal date.

3. The hospital adds an annual comparison of disclosure forms with Open Payments data for all physicians on purchasing committees.

4. The policy is amended to require committee members to sign a disclosure at each meeting.

Conclusion

The case is a failure to disclose and to abstain, made possible by a system that relied on self-reporting while public data sat unused. The fix is not to ban industry relationships but to check them and keep conflicted people out of decisions they could influence.

References

Campbell, E. G., Gruen, R. L., Mountford, J., Miller, L. G., Cleary, P. D., & Blumenthal, D. (2007). A national survey of physician-industry relationships. New England Journal of Medicine, 356(17), 1742-1750. https://doi.org/10.1056/NEJMsa064508

42 C.F.R. § 403.904 (2024). https://www.ecfr.gov/current/title-42/section-403.904

Institute of Medicine. (2009). Conflict of interest in medical research, education, and practice (B. Lo & M. J. Field, Eds.). National Academies Press. https://doi.org/10.17226/12598